There was no association however, between unsuccessful fibroscan measurements and liver enzymes (AST, ALT, GGT), platelet count, NAFLD score or FIB-4 score, suggesting that patients with advanced fibrosis were not missed with an unsuccessful fibroscan. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.